Tomislav Majic

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: March 18, 2026

Classifying Psychedelic-Related Complications.

Classifying Psychedelic-Related Complications.

Journal: Current topics in behavioral neurosciences

Published: February 26, 2026

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.

Journal: Current topics in behavioral neurosciences

Published: February 26, 2026

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Journal: Psychotherapy and psychosomatics

Published: February 02, 2026

Managing Psychological Challenges in the Subacute ("Afterglow") Window of Psychedelic Drug Effects.

Managing Psychological Challenges in the Subacute ("Afterglow") Window of Psychedelic Drug Effects.

Journal: Current topics in behavioral neurosciences

Published: December 19, 2025

Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management.

Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management.

Journal: Current topics in behavioral neurosciences

Published: December 05, 2025

The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.

The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.

Journal: Journal of psychopharmacology (Oxford, England)

Published: April 01, 2025

Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.

Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 30, 2024

On Minimizing Risk and Harm in the Use of Psychedelics.

On Minimizing Risk and Harm in the Use of Psychedelics.

Journal: Psychiatric research and clinical practice

Published: October 18, 2024

Towards a Better understanding of Persisting Perceptual Disturbances following the use of Classic Psychedelics.

Towards a Better understanding of Persisting Perceptual Disturbances following the use of Classic Psychedelics.

Journal: Fortschritte der Neurologie-Psychiatrie

Published: April 18, 2024

Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.

Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.

Journal: Scientific reports

Published: November 16, 2023

Psychiatric and non-psychiatric patients during the midst of Covid-19: Pandemic distress, psychosis and the belief in conspiracy theories.

Psychiatric and non-psychiatric patients during the midst of Covid-19: Pandemic distress, psychosis and the belief in conspiracy theories.

Journal: Journal of psychiatric research

Published: November 10, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026